105 related articles for article (PubMed ID: 21500194)
1. The novel DNA alkylating agent BO-1090 suppresses the growth of human oral cavity cancer in xenografted and orthotopic mouse models.
Sanjiv K; Su TL; Suman S; Kakadiya R; Lai TC; Wang HY; Hsiao M; Lee TC
Int J Cancer; 2012 Mar; 130(6):1440-50. PubMed ID: 21500194
[TBL] [Abstract][Full Text] [Related]
2. A combined DNA-affinic molecule and N-mustard alkylating agent has an anti-cancer effect and induces autophagy in oral cancer cells.
Lo WL; Chu PY; Lee TH; Su TL; Chien Y; Chen YW; Huang PI; Tseng LM; Tu PH; Kao SY; Lo JF
Int J Mol Sci; 2012; 13(3):3277-3290. PubMed ID: 22489152
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity.
Lee PC; Lee HJ; Kakadiya R; Sanjiv K; Su TL; Lee TC
Oncogene; 2013 Feb; 32(9):1144-54. PubMed ID: 22525278
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of autophagy enhances DNA damage-induced apoptosis by disrupting CHK1-dependent S phase arrest.
Liou JS; Wu YC; Yen WY; Tang YS; Kakadiya RB; Su TL; Yih LH
Toxicol Appl Pharmacol; 2014 Aug; 278(3):249-58. PubMed ID: 24823293
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Nagumo T; Takaoka S; Yoshiba S; Ohashi M; Shirota T; Hatori M; Isobe T; Tachikawa T; Shintani S
Oral Oncol; 2009 Sep; 45(9):766-70. PubMed ID: 19157955
[TBL] [Abstract][Full Text] [Related]
6. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Yasuda A; Kondo S; Nagumo T; Tsukamoto H; Mukudai Y; Umezawa K; Shintani S
Oral Oncol; 2011 May; 47(5):334-9. PubMed ID: 21459660
[TBL] [Abstract][Full Text] [Related]
8. BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.
Ambati SR; Shieh JH; Pera B; Lopes EC; Chaudhry A; Wong EW; Saxena A; Su TL; Moore MA
Oncotarget; 2016 Jul; 7(28):43062-43075. PubMed ID: 27248664
[TBL] [Abstract][Full Text] [Related]
9. Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo.
Chen YW; Lin GJ; Chia WT; Lin CK; Chuang YP; Sytwu HK
Oral Oncol; 2009 Jul; 45(7):562-8. PubMed ID: 19359213
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy evaluation of curcumin on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging.
Lin YC; Chen HW; Kuo YC; Chang YF; Lee YJ; Hwang JJ
Am J Chin Med; 2010; 38(2):343-58. PubMed ID: 20387230
[TBL] [Abstract][Full Text] [Related]
11. Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells.
Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Tang NY; Lu PJ; Weng JR; Chung JG
In Vivo; 2010; 24(3):287-91. PubMed ID: 20555000
[TBL] [Abstract][Full Text] [Related]
12. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.
Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M
Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of goniothalamin on Ca9-22 oral cancer cells through apoptosis, DNA damage and ROS induction.
Yen CY; Chiu CC; Haung RW; Yeh CC; Huang KJ; Chang KF; Hseu YC; Chang FR; Chang HW; Wu YC
Mutat Res; 2012 Sep; 747(2):253-8. PubMed ID: 22721813
[TBL] [Abstract][Full Text] [Related]
14. Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.
Bhuyan BK; Smith KS; Adams EG; Petzold GL; McGovren JP
Cancer Res; 1992 Oct; 52(20):5687-92. PubMed ID: 1394193
[TBL] [Abstract][Full Text] [Related]
15. The BRCA2 gene is a potential molecular target during 5-fluorouracil therapy in human oral cancer cells.
Nakagawa Y; Kajihara A; Takahashi A; Kondo N; Mori E; Kirita T; Ohnishi T
Oncol Rep; 2014 May; 31(5):2001-6. PubMed ID: 24627042
[TBL] [Abstract][Full Text] [Related]
16. Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G(1) arrest via the ATM/p53 pathway.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Baek SJ; Lee K; Kim CH
Arch Biochem Biophys; 2014 Mar; 545():133-40. PubMed ID: 24486404
[TBL] [Abstract][Full Text] [Related]
17. Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.
Chien MH; Lee TS; Kao C; Yang SF; Lee WS
Mol Carcinog; 2012 May; 51(5):389-99. PubMed ID: 21563217
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
19. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
[TBL] [Abstract][Full Text] [Related]
20. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
